Intellia Therapeutics (NTLA) PT Raised to $20 at Wedbush, Following Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Intellia Therapeutics (NTLA) Prices 5.48M Share Common Offering at $18.25/Sh
June 3, 2020 5:54 AM EDTIntellia Therapeutics, Inc. (NASDAQ: NTLA) announced today the pricing of an underwritten public offering of 5,479,453 shares of its common stock at a public offering price of $18.25 per share. Intellia also granted the underwriters a 30-day option to purchase up to an additional 821,917... More
